Recruiting Lung Cancer Studies in Yokohama
About Lung Cancer Clinical Trials in Yokohama
Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.
There are currently 1 lung cancer clinical trials recruiting participants in Yokohama, KANAGAWA. These studies are seeking a combined 90 participants. Research is being sponsored by Lantern Pharma Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lung Cancer Clinical Trials in Yokohama — FAQ
Are there lung cancer clinical trials in Yokohama?
Yes, there are 1 lung cancer clinical trials currently recruiting in Yokohama, KANAGAWA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Yokohama?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Yokohama research site will contact you about next steps.
Are clinical trials in Yokohama free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Yokohama studies also compensate for your time and travel.
What lung cancer treatments are being tested?
The 1 active trials in Yokohama are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.
Data updated March 2, 2026 from ClinicalTrials.gov